Faulty clinical laboratory results;Foutieve resultaten van veneuze bloedafname in het klinisch laboratorium

Tijdschrift voor Geneeskunde

Volumn 63, Issue 17, 2007, Pages 797-803

  Berth, M ^a   Bafort, K ^a   Bosmans, E ^a   Hens, K ^a   Salembier, G ^a   Stalpaert, M ^a   Uytterhoeven, M ^a   Verstraete, L ^a   Vereecken, A ^a  

^a Algemeen Medisch Laboratorium

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ANALYTICAL ERROR; ARTICLE; BLOOD SAMPLING; CLINICAL PRACTICE; DIAGNOSTIC ERROR; DIAGNOSTIC PROCEDURE; PATIENT CARE; QUALITY CONTROL; SEX DIFFERENCE;

EID: 34848874150     PISSN: 0371683X     EISSN: None     Source Type: Journal    
DOI: 10.2143/TVG.63.17.2000147     Document Type: Article

References (67)

1. KALRA J. Medical errors: impact on clinical laboratories and other critical areas. Clin Biochem 2004; 37: 1052-1062.
2. LIPPI G, GUIDI GC, MATTIUZZI C, PLEBANI M. Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med 2006; 44: 358-365.
3. BONINI P, PLEBANI M, CERIOTTI F, RUBBOLI F. Errors in laboratory medicine. Clin Chem 2002; 48: 691-698.
4. CARRARO P, SERVIDIO G, PLEBANI M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000; 46: 306-307.
5. TAMECHIKA Y, IWATANI Y, TOHYAMA K, ICHIHARA K. Insufficient filling of vacuum tubes as a cause of microhemolysis and elevated serum lactate dehydrogenase levels. Use of a data-mining technique in evaluation of questionable laboratory test results. Clin Chem Lab Med 2006; 44: 657-661.
6. LIPPI G, SALVAGNO GL, MONTAGNANA M, BROCCO G, GUIDI GC. Influence of hemolysis on routine clinical chemistry testing. Clin Chem Lab Med 2006; 44: 311-316.
7. NCCLS, H18-A3. Procedures for the handling and processing of blood specimens; Approved guideline - Third edition. Pennsylvania: Clinical and Laboratory Standards Institute (CLSI), 2003.
8. STAHL M, BRANDSLUND I. Controlled storage conditions prolong stability of biochemical components in whole blood. Clin Chem Lab Med 2005; 43: 210-215.
9. REHAK NN, CHIANG BT. Storage of whole blood: effect of temperature on the measured concentration of analytes in serum. Clin Chem 1988; 34: 2111-2114.
10. SINCLAIR D, BRISTON P, YOUNG R, PEPIN N. Seasonal pseudohyperkalaemia. J Clin Pathol 2003; 56: 385-388.
11. BUTTARELLO M. Quality specification in haematology: the automated blood cell count. Clin Chim Acta 2004; 346: 45-54.
12. KITCHEN S. Problems in laboratory monitoring of heparin dosage. Br J Haematol 2000; 111: 397-406.
13. NCCLS, H21-A4. Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays; Approved guidline - Fourth edition. Pennsylvania: Clinical and Laboratory Standards Institute (CLSI), 2003.
14. VAN GEEST-DAALDEROP JH, MULDER AB, BOONMAN-DE WINTER LJ, HOEKSTRA MM, VAN DEN BESSELAAR AM. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy. Clin Chem 2005; 51: 561-568.
15. NARAYANAN S. The preanalytic phase. An important component of laboratory medicine. Am J Clin Pathol 2000; 113: 429-452.
16. LIPPI G, BROCCO G, FRANCHINI M, SCHENA F, GUIDI G. Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls. Clin Chem Lab Med 2004; 42: 644-647.
17. YOUNG DS. Effects of preanalytical variables on clinical laboratory tests, 2nd ed. Washington, DC: AACC Press, 1997.
18. YOUNG DS, BERMES EW. Preanalytical variables and biological variation. In: Burtis CA, Ashwood ER, Bruns DE, eds. Tietz textbook of clinical chemistry and molecular diagnostics, 4th edition. St. Louis: Elsevier Saunders, 2006: 449-473.
19. DELANGHE J. Pitfalls in the determination of common analytes in the critically ill. Acta Clin Belg 2000; 55: 4-8.
20. YOUNG DS. Effects of drugs on clinical laboratory tests, 5th ed. Washington, DC: AACC Press, 1999.
21. KROLL MH, ELIN RJ. Interference with clinical laboratory analyses. Clin Chem 1994; 40 (11 Pt 1): 1996-2005.
22. KAZMIERCZAK SC, CATROU PG. Analytical interference. More than just a laboratory problem. Am J Clin Pathol 2000; 113: 9-11.
23. KROLL MH. Evaluating interference caused by lipemia. Clin Chem 2004; 50: 1968-1969.
24. STEEN G, VERMEER HJ, NAUS AJ, GOEVAERTS B, AGRICOLA PT, SCHOENMAKERS CH. Multicenter evaluation of the interference of hemoglobin, bilirubin and lipids on Synchron LX-20 assays. Clin Chem Lab Med 2006; 44: 413-419.
25. DE GREEF Y, CLAEYS R, MEBIS J, et al. Pseudo-trombopenie. Een niet altijd even goed gekend laboratoriumfenomeen. Tijdschr Geneesk 2005; 61: 294-299.
26. BRIGDEN ML, DALAL BI. Cell counter-related abnormalities. Lab Med 1999; 30: 325-334.
27. MIENDJE DEYI Y, GOUBAU P, BODEUS M. False-positive IgM antibody tests for cytomegalovirus in patients with acute Epstein-Barr virus infection. Eur J Clin Microbiol Infect Dis 2000; 19: 557-560.
28. Federale Overheidsdienst, Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu. Commissie voor Klinische Biologie. Dienst Laboratoria voor Klinische Biologie. Comites van Deskundigen. Globaal rapport. Externe kwaliteitevaluatie voor analysen klinische biologie: microbiologie/serologie/ parasitologie. Enquête 2005/3. Beschikbaar via http://www.iph.fgov.be/ ClinBiol/bckb33/activities/external_quality/rapports/_down/microbiologie/_nl/ 2005/2005_3_NL_MICROBIO.pdf.
29. SONNTAG O, SCHOLER A. Drug interference in clinical chemistry: recommendation of drugs and their concentrations to be used in drug interference studies. Ann Clin Biochem 2001; 38 (Pt 4): 376-385.
30. WEBER JA, VAN ZANTEN AP. Interferences in current methods for measurements of creatinine. Clin Chem 1991; 37: 695-700.
31. STEIMER W, MULLER C, EBER B. Digoxin assays: frequent, substantial, and potentially dangerous interference by spironolactone, canrenone, and other steroids. Clin Chem 2002; 48: 507-516.
32. PROCTOR KA, RAO LV, ROBERTS WL. Gadolinium magnetic resonance contrast agents produce analytic interference in multiple serum assays. Am J Clin Pathol 2004; 121: 282-292.
33. DELANGHE JR, HAMERS N, TAES YE, LIBEER JC. Interference of dextran in biuret-type assays of serum proteins. Clin Chem Lab Med 2005; 43: 71-74.
34. PETITCLERC C. Normality: the unreachable star? Clin Chem Lab Med 2004; 42: 698-701.
35. HENNY J, HYLTOFT PETERSEN P. Reference values: from philosophy to a tool for laboratory medicine. Clin Chem Lab Med 2004; 42: 686-691.
36. ZERAH S, MCMURRAY J, BOUSQUET B, et al. EC4 European Syllabus for Post-Graduate Training in Clinical Chemistry and Laboratory Medicine: version 3 - 2005. Clin Chem Lab Med 2006; 44: 110-120.
37. BURNETT D. ISO 15189:2003 - quality management, evaluation and continual improvement. Clin Chem Lab Med 2006; 44: 733-739.
38. NCCLS, H3-A5. Procedures for the collection of diagnostic blood specimens by venipuncture; Approved standard - Fifth edition. Pennsylvania: Clinical and Laboratory Standards Institute (CLSI), 2003.
39. ROTMENSCH S, COLE LA. False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations. Lancet 2000; 355: 712-715.
40. YOUNG IS. Interpretive comments on clinical biochemistry reports. J Clin Pathol 2005; 58: 575.
41. LAPOSATA M. Patient-specific narrative interpretations of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem 2004; 50: 471-472.
42. QUERALTO JM. Intraindividual reference values. Clin Chem Lab Med 2004; 42: 765-777.
43. PLEBANI M. Errors in clinical laboratories or errors in laboratory medicine? Clin Chem Lab Med 2006; 44: 750-759.
44. BLUMENTHAL D. The errors of our ways. Clin Chem 1997; 43 (8 Pt 1): 1305.
45. BARKER AJ, SLOMP J, DE VRIES T, et al. Adequate sampling in cryoglobulinemia: recommended warmly. Clin Chem Lab Med 2003; 41: 85-89.
46. KALLEMUCHIKKAL U, GOREVIC PD. Evaluation of cryoglobulins. Arch Pathol Lab Med 1999; 123: 119-125.
47. PREISSNER CM, O'KANE DJ, SINGH RJ, MORRIS JC, GREBE SK. Phantoms in the assay tube: heterophile antibody interferences in serum thyroglobulin assays. J Clin Endocrinol Metab 2003; 88: 3069-3074.
48. PREISSNER CM, DODGE LA, O'KANE DJ, SINGH RJ, GREBE SK. Prevalence of heterophilic antibody interference in eight automated tumor marker immunoassays. Clin Chem 2005; 51: 208-210.
49. KRICKA LJ. Human anti-animal antibody interferences in immunological assays. Clin Chem 1999; 45: 942-956.
50. FITZMAURICE TF, BROWN C, RIFAI N, WU AH, YEO KT. False increase of cardiac troponin I with heterophilic antibodies. Clin Chem 1998; 44: 2212-2214.
51. KRAHN J, PARRY DM, LEROUX M, DALTON J. High percentage of false positive cardiac troponin I results in patients with rheumatoid factor. Clin Biochem 1999; 32: 477-480.
52. DESPRES N, GRANT AM. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem 1998; 44: 440-454.
53. BERTH M, BOSMANS E, EVERAERT J, et al. Rheumatoid factor interference in the determination of carbohydrate antigen 19-9 (CA 19-9). Clin Chem Lab Med 2006; 44: 1137-1139.
54. PUI JC, POLLAK ES. Effect of lupus anticoagulants on INR with different thromboplastins. Blood Coagul Fibrinolysis 2000; 11: 579-581.
55. BLANCO AN, ALCIRA PEIRANO A, GROSSO SH, GENNARI LC, PEREZ BIANCO R, LAZZARI MA. A chromogenic substrate method for detecting and titrating anti-factor VIII antibodies in the presence of lupus anticoagulant. Haematologica 2002; 87: 271-278.
56. ROBERT A, LE QUERREC A, DELAHOUSSE B, et al. Control of oral anticoagulation in patients with the antiphospholipid syndrome - influence of the lupus anticoagulant on International Normalized Ratio. Groupe Methodologie en Hemostase du Groupe d'Etudes sur l'Hemostases et la Thrombose. Thromb Haemost 1998; 80: 99-103.
57. RAGLAND BD, REED CE, EILAND BM, et al. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance. Am J Clin Pathol 2003; 119: 66-71.
58. REMALEY AT, WILDING P. Macroenzymes: biochemical characterization, clinical significance, and laboratory detection. Clin Chem 1989; 35: 2261-2270.
59. VANDENBUSSCHE F, BERNARD D, ORLENT H. Geïsoleerde stijging van de serumactiviteit van aspartaataminotransferase bij een jonge patiënt zonder Symptomen: macro-AST. Ned Tijdschr Geneeskd 2005; 149: 2807-2809.
60. TAES YE, LOUAGIE H, YVERGNEAUX JP, et al. Prolonged hyperlipasemia attributable to a novel type of macrolipase. Clin Chem 2000; 46: 2008-2013.
61. GIBNEY J, SMITH TP, MCKENNA TJ. Clinical relevance of macroprolactin. Clin Endocrinol (Oxf) 2005; 62: 633-643.
62. THEUNISSEN C, DE SCHEPPER J, SCHIETTECATTE J, VERDOOD P, HOOGHE-PEETERS EL, VELKENIERS B. Macroprolactinemia: clinical significance and characterization of the condition. Acta Clin Belg 2005; 60: 190-197.
63. BERTH M, DELANGHE J. Protein precipitation as a possible important pitfall in the clinical chemistry analysis of blood samples containing monoclonal immunoglobulins: 2 case reports and a review of the literature. Acta Clin Belg 2004; 59: 263-273.
64. KOHSE KP, WISSER H. Antibodies as a source of analytical errors. J Clin Chem Clin Biochem 1990; 28: 881-892.
65. DASGUPTA A. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin. Am J Clin Pathol 2002; 118: 132-140.
66. ER TK, TSAI LY, JONG YJ, CHEN BH. Falsely elevated troponin I attributed to inadequate centrifugation using the Access immunoassay analyzer. Clin Chem Lab Med 2006; 44: 908-909.
67. BOWEN RA, CHAN Y, RUDDEL ME, et al. Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant silwet L-720. Clin Chem 2005; 51: 1874-1882.